Patten Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Patten Group’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-194	Closed	-$10K	–	615
2017 Q4	$10K	Sell	194 -14	-7%	-$766	﹤0.01%	495
2017 Q3	$12K	Hold	208	–	–	﹤0.01%	464
2017 Q2	$12K	Sell	208 -43	-17%	-$2.45K	﹤0.01%	480
2017 Q1	$14K	Buy	+251	New	+$12.4K	0.01%	443

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Patten Group's BIVV Position: Q1 2018 in Review

Patten Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 194 shares — an estimated $10K sold.

Patten Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $14K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Patten Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Patten Group sold 194 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $10K.
Patten Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Patten Group's Bioverativ Inc. Common Stock position peaked at $14K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Patten Group's 13F filing for Q1 2018, filed 11 May 2018.